These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 23223899)

  • 1. Immune modulation of effector CD4+ and regulatory T cell function by sorafenib in patients with hepatocellular carcinoma.
    Cabrera R; Ararat M; Xu Y; Brusko T; Wasserfall C; Atkinson MA; Chang LJ; Liu C; Nelson DR
    Cancer Immunol Immunother; 2013 Apr; 62(4):737-46. PubMed ID: 23223899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of serum and soluble CD25 (sCD25) on regulatory and effector T-cell function in hepatocellular carcinoma.
    Cabrera R; Ararat M; Eksioglu EA; Cao M; Xu Y; Wasserfall C; Atkinson MA; Liu C; Nelson DR
    Scand J Immunol; 2010 Oct; 72(4):293-301. PubMed ID: 20883314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity.
    Chen ML; Yan BS; Lu WC; Chen MH; Yu SL; Yang PC; Cheng AL
    Int J Cancer; 2014 Jan; 134(2):319-31. PubMed ID: 23818246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib.
    Zhou SL; Zhou ZJ; Hu ZQ; Huang XW; Wang Z; Chen EB; Fan J; Cao Y; Dai Z; Zhou J
    Gastroenterology; 2016 Jun; 150(7):1646-1658.e17. PubMed ID: 26924089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sorafenib reduces hepatic infiltrated regulatory T cells in hepatocellular carcinoma patients by suppressing TGF-beta signal.
    Wang Q; Yu T; Yuan Y; Zhuang H; Wang Z; Liu X; Feng M
    J Surg Oncol; 2013 Mar; 107(4):422-7. PubMed ID: 22833259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting effect of Astragalus polysaccharides on the functions of CD4+CD25 highTreg cells in the tumor microenvironment of human hepatocellular carcinoma.
    Li Q; Bao JM; Li XL; Zhang T; Shen XH
    Chin Med J (Engl); 2012 Mar; 125(5):786-93. PubMed ID: 22490576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CD4+CD25+CD127
    Zhou W; Deng J; Chen Q; Li R; Xu X; Guan Y; Li W; Xiong X; Li H; Li J; Cai X
    Int J Med Sci; 2020; 17(6):712-719. PubMed ID: 32218692
    [No Abstract]   [Full Text] [Related]  

  • 8. Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells.
    Sprinzl MF; Reisinger F; Puschnik A; Ringelhan M; Ackermann K; Hartmann D; Schiemann M; Weinmann A; Galle PR; Schuchmann M; Friess H; Otto G; Heikenwalder M; Protzer U
    Hepatology; 2013 Jun; 57(6):2358-68. PubMed ID: 23424039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Jak inhibitor CP-690,550 preserves the function of CD4CD25FoxP3 regulatory T cells and inhibits effector T cells.
    Sewgobind VD; Quaedackers ME; van der Laan LJ; Kraaijeveld R; Korevaar SS; Chan G; Weimar W; Baan CC
    Am J Transplant; 2010 Aug; 10(8):1785-95. PubMed ID: 20626385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma cell supernatants increase expansion and function of CD4(+)CD25(+) regulatory T cells.
    Cao M; Cabrera R; Xu Y; Firpi R; Zhu H; Liu C; Nelson DR
    Lab Invest; 2007 Jun; 87(6):582-90. PubMed ID: 17372588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Proliferation of CD4+ CD25+ regulatory T cells of rat by different cytokines in vitro].
    Wang ZH; Zhu JY; Li T; Leng XS
    Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(12):844-7. PubMed ID: 18756991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
    Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
    J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
    Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
    Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different radiosensitivity of CD4(+)CD25(+) regulatory T cells and effector T cells to low dose gamma irradiation in vitro.
    Cao M; Cabrera R; Xu Y; Liu C; Nelson D
    Int J Radiat Biol; 2011 Jan; 87(1):71-80. PubMed ID: 20958220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25- effector T cells.
    Passerini L; Allan SE; Battaglia M; Di Nunzio S; Alstad AN; Levings MK; Roncarolo MG; Bacchetta R
    Int Immunol; 2008 Mar; 20(3):421-31. PubMed ID: 18270368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.
    Kakita N; Kanto T; Itose I; Kuroda S; Inoue M; Matsubara T; Higashitani K; Miyazaki M; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    Int J Cancer; 2012 Dec; 131(11):2573-83. PubMed ID: 22419479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
    Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS
    Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human regulatory T cell suppressive function is independent of apoptosis induction in activated effector T cells.
    Vercoulen Y; Wehrens EJ; van Teijlingen NH; de Jager W; Beekman JM; Prakken BJ
    PLoS One; 2009 Sep; 4(9):e7183. PubMed ID: 19779623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective expansion of memory CD4(+) T cells by mitogenic human CD28 generates inflammatory cytokines and regulatory T cells.
    Singh M; Basu S; Camell C; Couturier J; Nudelman RJ; Medina MA; Rodgers JR; Lewis DE
    Eur J Immunol; 2008 Jun; 38(6):1522-32. PubMed ID: 18446791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Endothelial Cells Modulate CD4
    Lim WC; Olding M; Healy E; Millar TM
    Front Immunol; 2018; 9():565. PubMed ID: 29628925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.